Document is current
Any future updates will be listed below
-
Authors
Chihota, Violet https://orcid.org/0000-0003-1444-9266
Gombe, Makaita
Gupta, Amita
Salazar-Austin, Nicole
Ryckman, Tess
Hoffmann, Christopher J.
LaCourse, Sylvia
Mathad, Jyoti S.
Mave, Vidya
Dooley, Kelly E.
Chaisson, Richard E.
Churchyard, Gavin
- License Information
-
More Information
Article History
Accepted: 20 November 2024
First Online: 28 December 2024
Declarations
:
: GC and VC were supported by Unitaid through the IMPAACT4TB project (2017-20-IMPAACT4TB). GC is supported by an NIH grant UM1AI068636 for the PHOENIx MDR TB trial. REC was supported by Unitaid through the IMPAACT4TB project (2017-20-IMPAACT4TB) and NIH grant P30AI18436. KED is supported by NIH/NIAID K24AI150349. MG, AG, NSA, TR, CJH, SL, JSM, and VM have not received funding.
: VC, MG, AG, NSA, TR, CJM, JSM, VM, and KED have no relevant financial or non-financial interests to disclose. SML is funded by Merck through her institution for C19-related research and declares UpToDate—royalties for a chapter on TB infection in pregnancy. REC’s spouse owns stock in Merck. RC and GC have consulted for Johnson & Johnson.
: No data are available as this was a review.
: Not applicable. The manuscript is a review and does not report results of a study that involved human participants, their data, or biological material.
: Not applicable. The manuscript does not contain identifiable patient data.
: Not applicable. The article does not contain clinical photos of patients or patient data that could be identifiable.
: VC and GC conceptualized and designed the outline of the paper. All authors (VC, MG, AG, NSA, TR, CJM, SL, JSM, VM, KED, REC, GC) contributed to specific sections of the manuscript and reviewed the paper. All authors read and approved the final version.
